0000000001252804

AUTHOR

M Quarantelli

showing 3 related works from this author

Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP).

2013

Multiple Sclerosis Natalizumab TySTOPSettore MED/26 - Neurologia
researchProduct

GREY MATTER ATROPHY AND FATIGUE IN MULTIPLE SCLEROSIS: A CORRELATION EVIDENT ONLY IN PATIENTS WITH LOW DISABILITY

2006

researchProduct

Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study

2012

natalizumab multiple sclerosis
researchProduct